New York Devil’s Claw Demand Returns DNA Barcoding To Industry Crosshairs
This article was originally published in The Tan Sheet
Executive Summary
NY AG Schneiderman’s demands that 13 firms pull devil's claw supplements from the market impress supplement industry stakeholders no more than his February orders, also based on DNA barcoding alone, for GNC and three mass merchandizers to remove allegedly adulterated herbal supplements from stores.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.